Interleukin-1 receptor antagonist: discovery, structure and properties

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Interleukin-1 (IL-1) is a key mediator of inflammation.
• The IL-1 family includes several related proteins with diverse functions.
• Understanding IL-1 regulation is crucial for controlling inflammatory diseases.

Purpose of the Study:

• To characterize the newly discovered Interleukin-1 receptor antagonist (IL-1ra).
• To investigate the inhibitory potential of IL-1ra on IL-1 mediated cellular responses.
• To explore the physiological relevance of IL-1ra as a natural cytokine inhibitor.

Main Methods:

• Sequence homology analysis comparing IL-1ra to IL-1 beta.
• Binding assays with human types I and II IL-1 receptors.
• In vitro functional assays to assess IL-1ra's effect on thymocytes, fibroblasts, endothelial cells, and bone cells.
• In vivo studies to evaluate IL-1ra's anti-inflammatory properties.

Main Results:

• IL-1ra shares 30% amino acid homology with IL-1 beta.
• IL-1ra binds to IL-1 receptors without inducing cellular activation.
• IL-1ra effectively blocks IL-1's in vitro stimulatory effects on various cell types.
• IL-1ra demonstrates potent inhibition of IL-1's in vivo inflammatory effects.

Conclusions:

• IL-1ra is the first identified naturally occurring inhibitor of a cytokine.
• IL-1ra acts by blocking IL-1 receptor binding and downstream signaling.
• IL-1ra plays a significant role in modulating IL-1 activity in both health and disease.